Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 17, 2005, Pages 2637-2642

  Wang, Yong Li ^a   Li, Ming Hua ^a   Cheng, Ying Sheng ^a   Shi, Hai Bing ^b   Fan, Hai Lun ^c  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

ECAs; HCC

Indexed keywords

CISPLATIN; EPIRUBICIN; FLOXURIDINE; IODINATED POPPYSEED OIL; SODIUM CHLORIDE;

ADULT; AGED; ANGIOGENESIS; ARTERY OCCLUSION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SIZE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLLATERAL CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEPATIC ARTERY; HUMAN; LIVER ANGIOGRAPHY; LIVER BLOOD FLOW; LIVER CELL CARCINOMA; MALE; PATHOLOGICAL ANATOMY; TREATMENT CONTRAINDICATION; TUMOR VASCULARIZATION;

EID: 18944402687     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i17.2637     Document Type: Article

References (37)

1. Sturm JW, Keese M. multimodal treatment of hepatocellular carcinoma (HCC). Onkologie 2004; 27: 294-303
2. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 2004; 139: 766-774
3. Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK. Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma. Alzheng 2004; 23: 829-832
4. Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 2004; 54: 415-420
5. Testa R, Testa E, Giannini E, Botta F, Malfatti F, Chiarbonello B, Fumagalli A, Polegato S, Podesta E, Romagnoli P, Risso D, Cittadini G, De Caro G. Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer liver italian program (CLIP) and model for end-stage liver disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther 2003; 17: 1563-1569
6. Ebied OM, Federle MP, Carr BI, Pealer KM, Li W, Amesur N, Zajko A. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer 2003; 97: 1042-1050
7. Ahrar K, Gupta S. Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes. Surg Oncol Clin N Am 2003; 12: 105-126
8. Trinchet JC, Ganne-Carrie N, Beaugrand M. Review article: intra-arterial treatments in patients with hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17 (Suppl 2): 111-118
9. Xiao E, Li D, Shen S, Zhou S, Tan L, Wang Y, Luo J, Wu Y, Tan C, Liu H, Zhu H. Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells. Chin Med J 2003; 116: 203-207
10. O'Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 2003; 90: 325-331
11. Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, Chung JW, Park JH, Kim CY. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol 2002; 20: 4459-4465
12. Wakabayashi H, Ushiyama T, Ishimura K, Izuishi K, Karasawa Y, Masaki T, Watanabe S, Kuriyama S, Maeta H. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J Surg Oncol 2003; 82: 98-103
13. Park SI, Lee do Y, Won JY, Lee JT. Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries. J Vasc Interv Radiol 2003; 14: 461-468
14. Sasaki Y, Imaoka S, Nakano H, Tamura S, Aono Y, Furukawa H, Ishikawa O, Kabuto T, Hiratsuka M, Kameyama M, Ohigashi H, Nakamori S, Yasuda T, Iwanaga T, Kasugai H, Fujita M, Hosomi N. Hepatic resection with "wrapping therapy" for advanced hepatocellular carcinoma uncontrolled by arterial embolization. Gan To Kagaku Ryoho 1996; 23: 1588-1591
15. Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH. A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 mo) survival group and a long-term (over 24 mo) survival group after treatment with transcatheter arterial chemoembolization. Taehan Kan Hakhoe Chi 2002; 8: 189-200
16. Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol 2003; 98: 1181-1185
17. Li C, Guo Y, Tian G, Shi Z, Liu D, Zeng H, Jiang W, Li H, Zhou C. Extrahepatic arterial blood supply of hepatocellular carcinoma and interventional treatment. Zhonghua Zhongliu Zazhi 2002; 24: 163-166
18. Puleo S, Mauro L, Gagliano G, Lombardo R, Li Destri G, Petrillo G, Di Carlo I. Liver damage after transarterial chemoembolization without embolizing agent in unresectable hepatocellular carcinoma. Tumori 2003; 89: 285-287
19. Okazaki M, Yamasaki S, Ono H, Higashihara H, Koganemaru F, Kimura S, Kuroda Y, Sato S, Ryu K, Ohtsubo T. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology 1993; 40: 320-323
20. Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 1982; 144: 485-494
21. Shibata T, Kojima N, Tabuchi T, Itoh K, Konishi J. Transcatheter arterial chemoembolization through collateral arteries for hepatocellular carcinoma after arterial occlusion. Radiat Med 1998; 16: 251-256
22. Chung JW, Park JH. Extrahepatic collaterals in hepatocellular carcinoma. Man Chung Han, Jae Hyung Park, eds. Interventional therapy. Seoul Korea 1999: 133-145
23. Eurvilaichit C. Outcome of transcatheter oily chemoembolization in patients with hepatocellular carcinoma. Hepatogastroenterology 2004; 51: 20-24
24. Miyayama S, Matsui O, Nishida H, Yamamori S, Minami T, Shinmura R, Kozaka K, Notsumata K, Toya D, Tanaka N, Mitsui T, Nishijima H. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol 2003; 14(9 Pt 1): 1155-1161
25. Gates J, Hartnell GG, Stuart KE, Clouse ME. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 1999; 19: 399-414
26. Kim DE, Yoon HK, Ko GY, Kwon JS, Song HY, Sung KB. Hepatic falciform artery: is prophylactic embolization needed before short-term hepatic arterial chemoinfusion? Am J Roentgenol 1999; 172: 1597-1599
27. Okino Y, Kiyosue H, Matsumoto S, Takaji R, Yamada Y, Mori H. Hepatocellular carcinoma: prediction of blood supply from right inferior phrenic artery by multiphasic CT. J Comput Assist Tomogr 2003; 27: 341-346
28. Miyayama S, Matsui O, Taki K, Minami T, Ito C, Shinmura R, Takamatsu S, Kobayashi M, Notsumata K, Toya D, Tanaka N, Kozaka K. Transcatheter arterial chemoembolization for hepatocellular carcinoma fed by the reconstructed inferior phrenic artery: anatomical and technical analysis. J Vasc Interv Radiol 2004; 15: 815-823
29. Seki S, Kitada T, Sakaguchi H, Nakatani K, Kamino T, Nakamura K, Yamada R. Cardiac tamponade caused by spontaneous rupture of mediastinal lymph node metastasis of hepatocellular carcinoma. J Gastroenterol Hepatol 2001; 16: 702-704
30. Lee JH, Chon CY, Ahn SH, Moon BS, Kim JH, Paik YH, Han KH, Lee JT, Lee DY, Moon YM. An ischemic skin lesion after chemoembolization of the right internal mammary artery in a patient with hepatocellular carcinoma. Yonsei Med J 2001; 42: 137-141
31. Nakai M, Sato M, Kawai N, Minamiguchi H, Masuda M, Tanihata H, Takeuchi T, Terada M, Kishi K. Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology 2001; 219: 147-152
32. Liu HJ, Chen TS, Lee RC, Ho DM, Lin JT, Chu LS, Chang FY. Abdominal wall necrosis following transcatheter arterial chemoembolization for hepatocellular carcinoma. Zhonghua Yixue Zazhi 2000; 63: 838-843
33. Memis A, Oran I, Calli C, Yuzer Y, Mentes A. Transcatheter arterial embolization of internal mammary artery in a hepatocellular carcinoma with abdominal wall invasion. Eur J Radiol 1998; 28: 160-163
34. Kanetsuki I, Hori A, Ohshiro K, Nishi H, Yasutani T, Sueyoshi T, Tanaka H. Left lobe recurrent hepatocellular carcinoma treated with lipiodol-TAE via the left internal mammary artery. Cardiovasc Intervent Radiol 1997; 20: 387-389
35. Eurvilaichit C, Chuapetcharasopon C. Hepatic arterial collaterals after transcatheter oily chemoembolization of hepatocellular carcinoma. J Med Assoc Thai 2001; 84: 75-84
36. Sasaki Y, Imaoka S, Shibata T, Ishikawa O, Iwanaga T, Kasugai H, Fujita M. Decollateralization with silicone rubber sheeting for advanced hepatocellular carcinoma: a preliminary report. Surgery 1990; 108: 840-846
37. Won JY, Lee do Y, Lee JT, Park SI, Kim MJ, Yoo HS, Suh H, Park SJ. Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2003; 26: 136-140